Aconitase Causes Iron Toxicity in Drosophila pink1 Mutants

The PTEN-induced kinase 1 (PINK1) is a mitochondrial kinase, and pink1 mutations cause early onset Parkinson's disease (PD) in humans. Loss of pink1 in Drosophila leads to defects in mitochondrial function, and genetic data suggest that another PD-related gene product, Parkin, acts with pink1 to regulate the clearance of dysfunctional mitochondria (mitophagy). Consequently, pink1 mutants show an accumulation of morphologically abnormal mitochondria, but it is unclear if other factors are involved in pink1 function in vivo and contribute to the mitochondrial morphological defects seen in specific cell types in pink1 mutants. To explore the molecular mechanisms of pink1 function, we performed a genetic modifier screen in Drosophila and identified aconitase (acon) as a dominant suppressor of pink1. Acon localizes to mitochondria and harbors a labile iron-sulfur [4Fe-4S] cluster that can scavenge superoxide to release hydrogen peroxide and iron that combine to produce hydroxyl radicals. Using Acon enzymatic mutants, and expression of mitoferritin that scavenges free iron, we show that [4Fe-4S] cluster inactivation, as a result of increased superoxide in pink1 mutants, results in oxidative stress and mitochondrial swelling. We show that [4Fe-4S] inactivation acts downstream of pink1 in a pathway that affects mitochondrial morphology, but acts independently of parkin. Thus our data indicate that superoxide-dependent [4Fe-4S] inactivation defines a potential pathogenic cascade that acts independent of mitophagy and links iron toxicity to mitochondrial failure in a PD–relevant model.

[1]  Houeto Jean-Luc [Parkinson's disease]. , 2022, La Revue du praticien.

[2]  Janaka N. Edirisinghe,et al.  Vitamin K2 Is a Mitochondrial Electron Carrier That Rescues Pink1 Deficiency , 2012, Science.

[3]  H. Koh,et al.  PINK1 as a molecular checkpoint in the maintenance of mitochondrial function and integrity , 2012, Molecules and cells.

[4]  H. Kim,et al.  Silent Information Regulator 2 (Sir2) and Forkhead Box O (FOXO) Complement Mitochondrial Dysfunction and Dopaminergic Neuron Loss in Drosophila PTEN-induced Kinase 1 (PINK1) Null Mutant* , 2012, The Journal of Biological Chemistry.

[5]  R. Youle,et al.  PINK1- and Parkin-mediated mitophagy at a glance , 2012, Journal of Cell Science.

[6]  P. Verstreken,et al.  The Yeast Complex I Equivalent NADH Dehydrogenase Rescues pink1 Mutants , 2012, PLoS genetics.

[7]  B. Lu,et al.  Mitochondrial dynamics and mitophagy in Parkinson's disease: disordered cellular power plant becomes a big deal in a major movement disorder , 2011, Current Opinion in Neurobiology.

[8]  Su Guo,et al.  The PINK1/Parkin pathway regulates mitochondrial dynamics and function in mammalian hippocampal and dopaminergic neurons. , 2011, Human molecular genetics.

[9]  Kindiya D. Geghman,et al.  Pink1 regulates the oxidative phosphorylation machinery via mitochondrial fission , 2011, Proceedings of the National Academy of Sciences.

[10]  O. Shirihai,et al.  The interplay between mitochondrial dynamics and mitophagy. , 2011, Antioxidants & redox signaling.

[11]  H. Hsieh-Li,et al.  Mitochondrial Dysfunction and Oxidative Stress Contribute to the Pathogenesis of Spinocerebellar Ataxia Type 12 (SCA12)* , 2011, The Journal of Biological Chemistry.

[12]  P. Verstreken,et al.  Loss of Skywalker Reveals Synaptic Endosomes as Sorting Stations for Synaptic Vesicle Proteins , 2011, Cell.

[13]  S. Weber,et al.  The PINK1/Parkin-mediated mitophagy is compromised by PD-associated mutations , 2010, Autophagy.

[14]  Ted M. Dawson,et al.  Genetic Animal Models of Parkinson's Disease , 2010, Neuron.

[15]  J. T. Greenamyre,et al.  Mitochondrial iron metabolism and its role in neurodegeneration. , 2010, Journal of Alzheimer's disease : JAD.

[16]  D. Sgroi,et al.  Negative feedback control of HIF-1 through REDD1-regulated ROS suppresses tumorigenesis , 2010, Proceedings of the National Academy of Sciences.

[17]  Fabienne C. Fiesel,et al.  PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1 , 2010, Nature Cell Biology.

[18]  Atsushi Tanaka,et al.  PINK1 Is Selectively Stabilized on Impaired Mitochondria to Activate Parkin , 2010, PLoS biology.

[19]  Rachel Jones The Roles of PINK1 and Parkin in Parkinson's Disease , 2010, PLoS biology.

[20]  J. Schaack,et al.  Oxidative Inactivation of Mitochondrial Aconitase Results in Iron and H2O2-Mediated Neurotoxicity in Rat Primary Mesencephalic Cultures , 2009, PloS one.

[21]  R. Habets,et al.  Tweek, an Evolutionarily Conserved Protein, Is Required for Synaptic Vesicle Recycling , 2009, Neuron.

[22]  J. Connor,et al.  Iron, the substantia nigra and related neurological disorders. , 2009, Biochimica et biophysica acta.

[23]  Victor Tapias,et al.  A highly reproducible rotenone model of Parkinson's disease , 2009, Neurobiology of Disease.

[24]  P. Verstreken,et al.  Parkinson's disease mutations in PINK1 result in decreased Complex I activity and deficient synaptic function , 2009, EMBO molecular medicine.

[25]  Hansong Deng,et al.  The Parkinson's disease genes pink1 and parkin promote mitochondrial fission and/or inhibit fusion in Drosophila , 2008, Proceedings of the National Academy of Sciences.

[26]  Jie Shen,et al.  Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress , 2008, Proceedings of the National Academy of Sciences.

[27]  M. Beal,et al.  Pink1 regulates mitochondrial dynamics through interaction with the fission/fusion machinery , 2008, Proceedings of the National Academy of Sciences.

[28]  Angela C. Poole,et al.  The PINK1/Parkin pathway regulates mitochondrial morphology , 2008, Proceedings of the National Academy of Sciences.

[29]  B. Dickson,et al.  A genome-wide transgenic RNAi library for conditional gene inactivation in Drosophila , 2007, Nature.

[30]  R. Maeda,et al.  An optimized transgenesis system for Drosophila using germ-line-specific φC31 integrases , 2007, Proceedings of the National Academy of Sciences.

[31]  Christina Chan,et al.  Hydrogen peroxide and hydroxyl radicals mediate palmitate-induced cytotoxicity to hepatoma cells: Relation to mitochondrial permeability transition , 2007, Free radical research.

[32]  Hugo J. Bellen,et al.  P[acman]: A BAC Transgenic Platform for Targeted Insertion of Large DNA Fragments in D. melanogaster , 2006, Science.

[33]  M. Beal,et al.  Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Sunhong Kim,et al.  Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin , 2006, Nature.

[35]  Changan Jiang,et al.  Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin , 2006, Nature.

[36]  B. Dunkov,et al.  Characterization of mitochondrial ferritin in Drosophila. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[37]  P. Verstreken,et al.  Synaptic Mitochondria Are Critical for Mobilization of Reserve Pool Vesicles at Drosophila Neuromuscular Junctions , 2005, Neuron.

[38]  Jin Man Kim,et al.  Parkin negatively regulates JNK pathway in the dopaminergic neurons of Drosophila. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[39]  Sunil Q. Mehta,et al.  The v-ATPase V0 Subunit a1 Is Required for a Late Step in Synaptic Vesicle Exocytosis in Drosophila , 2005, Cell.

[40]  Robin Shattock,et al.  In Vitro and In Vivo: The Story of Nonoxynol 9 , 2005, Journal of acquired immune deficiency syndromes.

[41]  F. Zoccarato,et al.  Dopamine-derived dopaminochrome promotes H(2)O(2) release at mitochondrial complex I: stimulation by rotenone, control by Ca(2+), and relevance to Parkinson disease. , 2005, The Journal of biological chemistry.

[42]  S. Birman,et al.  Chronic Exposure to Rotenone Models Sporadic Parkinson's Disease in Drosophila melanogaster , 2004, The Journal of Neuroscience.

[43]  G. Mardon,et al.  Drosophila parkin mutants have decreased mass and cell size and increased sensitivity to oxygen radical stress , 2004, Development.

[44]  T. Dawson,et al.  Molecular Pathways of Neurodegeneration in Parkinson's Disease , 2003, Science.

[45]  W. Dauer,et al.  Parkinson's Disease Mechanisms and Models , 2003, Neuron.

[46]  F. Petrat,et al.  Selective determination of mitochondrial chelatable iron in viable cells with a new fluorescent sensor. , 2002, The Biochemical journal.

[47]  Todd B. Sherer,et al.  Chronic systemic pesticide exposure reproduces features of Parkinson's disease , 2000, Nature Neuroscience.

[48]  B. Kalyanaraman,et al.  Mitochondrial Aconitase Is a Source of Hydroxyl Radical , 2000, The Journal of Biological Chemistry.

[49]  A. Cederbaum,et al.  Mitochondrial permeability transition induced by 1-hydroxyethyl radical. , 2000, Free radical biology & medicine.

[50]  S. Berman,et al.  Dopamine Oxidation Alters Mitochondrial Respiration and Induces Permeability Transition in Brain Mitochondria , 1999, Journal of neurochemistry.

[51]  I. Fridovich,et al.  Critical evaluation of the use of hydroethidine as a measure of superoxide anion radical. , 1998, Free radical biology & medicine.

[52]  A. Vercesi,et al.  The Role of Reactive Oxygen Species in Mitochondrial Permeability Transition , 1997, Bioscience reports.

[53]  J. Turrens Superoxide Production by the Mitochondrial Respiratory Chain , 1997, Bioscience reports.

[54]  B. Robinson,et al.  Mitochondrial complex I deficiency leads to increased production of superoxide radicals and induction of superoxide dismutase. , 1996, The Journal of clinical investigation.

[55]  R. Klausner,et al.  The bifunctional iron-responsive element binding protein/cytosolic aconitase: the role of active-site residues in ligand binding and regulation. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[56]  G. Dryhurst,et al.  Effects of L-cysteine on the oxidation chemistry of dopamine: new reaction pathways of potential relevance to idiopathic Parkinson's disease. , 1994, Journal of medicinal chemistry.

[57]  H. Beinert,et al.  Aconitase, a two‐faced protein: enzyme and iron regulatory factor 1 2 , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[58]  C. Stout,et al.  Crystal structures of aconitase with isocitrate and nitroisocitrate bound. , 1993, Biochemistry.

[59]  D. Flint,et al.  The inactivation of Fe-S cluster containing hydro-lyases by superoxide. , 1993, The Journal of biological chemistry.

[60]  P. R. Gardner,et al.  Superoxide sensitivity of the Escherichia coli aconitase. , 1991, The Journal of biological chemistry.

[61]  P Riederer,et al.  Selective Increase of Iron in Substantia Nigra Zona Compacta of Parkinsonian Brains , 1991, Journal of neurochemistry.

[62]  P. R. Gardner,et al.  Superoxide sensitivity of the Escherichia coli 6-phosphogluconate dehydratase. , 1991, The Journal of biological chemistry.

[63]  K. Jellinger,et al.  Normal Mitochondrial Genome in Brain from Patients with Parkinson's Disease and Complex I Defect , 1990, Journal of neurochemistry.

[64]  A. H. V. Schapira,et al.  MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE , 1989, The Lancet.

[65]  L. Luo,et al.  A protocol for dissecting Drosophila melanogaster brains for live imaging or immunostaining , 2006, Nature Protocols.

[66]  I. Fridovich,et al.  The role of O2.- in the production of HO.: in vitro and in vivo. , 1994, Free radical biology & medicine.

[67]  D. Brahams Medicine and the law. Consent to medical treatment in prison. , 1983, Lancet.